Cytokines in the pathogenesis of rheumatoid arthritis (original) (raw)
Firestein, G. S. Evolving concepts of rheumatoid arthritis. Nature423, 356–361 (2003). This is an elegant overview of the pathogenesis of rheumatoid arthritis. ArticleCASPubMed Google Scholar
Maini, R. N. & Taylor, P. C. Anti-cytokine therapy for rheumatoid arthritis. Annu. Rev. Med.51, 207–229 (2000). ArticleCASPubMed Google Scholar
McInnes, I. B. & Liew, F. Y. Cytokine networks—towards new therapies for rheumatoid arthritis. Nature Clin. Pract. Rheumatol.1, 31–39 (2005). ArticleCAS Google Scholar
van der Helm-van Mil, A. H., Wesoly, J. Z. & Huizinga, T. W. Understanding the genetic contribution to rheumatoid arthritis. Curr. Opin. Rheumatol.17, 299–304 (2005). ArticlePubMed Google Scholar
Klareskog, L., Padyukov, L. & Alfredsson, L. Smoking as a trigger for inflammatory rheumatic diseases. Curr. Opin. Rheumatol.19, 49–54 (2007). ArticleCASPubMed Google Scholar
Jimenez-Boj, E. et al. Interaction between synovial inflammatory tissue and bone marrow in rheumatoid arthritis. J. Immunol.175, 2579–2588 (2005). ArticleCASPubMed Google Scholar
Nishimoto, N. & Kishimoto, T. Interleukin 6: from bench to bedside. Nature Clin. Pract. Rheumatol.2, 619–626 (2006). ArticleCAS Google Scholar
Sattar, N., McCarey, D. W., Capell, H. & McInnes, I. B. Explaining how 'high-grade' systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation108, 2957–2963 (2003). ArticlePubMed Google Scholar
Panayi, G. S. Even though T-cell-directed trials have been of limited success, is there reason for optimism? Nature Clin. Pract. Rheumatol.2, 58–59 (2006). Article Google Scholar
Keystone, E. C. Abandoned therapies and unpublished trials in rheumatoid arthritis. Curr. Opin. Rheumatol.15, 253–258 (2003). ArticleCASPubMed Google Scholar
Genovese, M. C. et al. Abatacept for rheumatoid arthritis refractory to tumor necrosis factor α inhibition. N. Engl. J. Med.353, 1114–1123 (2005). ArticleCASPubMed Google Scholar
McInnes, I. B., Leung, B. P., Sturrock, R. D., Field, M. & Liew, F. Y. Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-α production in rheumatoid arthritis. Nature Med.3, 189–195 (1997). ArticleCASPubMed Google Scholar
Schulze-Koops, H. & Kalden, J. R. The balance of Th1/Th2 cytokines in rheumatoid arthritis. Best Pract. Res. Clin. Rheumatol.15, 677–691 (2001). ArticleCASPubMed Google Scholar
Lubberts, E., Koenders, M. I. & van den Berg, W. B. The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models. Arthritis Res. Ther.7, 29–37 (2005). ArticleCASPubMed Google Scholar
Manoury-Schwartz, B. et al. High susceptibility to collagen-induced arthritis in mice lacking IFN-γ receptors. J. Immunol.158, 5501–5506 (1997). CASPubMed Google Scholar
Vermeire, K. et al. Accelerated collagen-induced arthritis in IFN-γ receptor-deficient mice. J. Immunol.158, 5507–5513 (1997). CASPubMed Google Scholar
Murphy, C. A. et al. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med.198, 1951–1957 (2003). This is a critical paper defining the role of TH17 cells in CIA. ArticleCASPubMedPubMed Central Google Scholar
Wang, J. et al. Transcription factor T-bet regulates inflammatory arthritis through its function in dendritic cells. J. Clin. Invest.116, 414–421 (2006). ArticleCASPubMedPubMed Central Google Scholar
Hirota, K. et al. T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis. J. Exp. Med.204, 41–47 (2007). ArticleCASPubMedPubMed Central Google Scholar
Firestein, G. S. & Zvaifler, N. J. Peripheral blood and synovial fluid monocyte activation in inflammatory arthritis. II. Low levels of synovial fluid and synovial tissue interferon suggest that γ-interferon is not the primary macrophage activating factor. Arthritis Rheum.30, 864–871 (1987). ArticleCASPubMed Google Scholar
Kanik, K. S. et al. Distinct patterns of cytokine secretion characterize new onset synovitis versus chronic rheumatoid arthritis. J. Rheumatol.25, 16–22 (1998). CASPubMed Google Scholar
Ronnelid, J. et al. Production of T-cell cytokines at the single-cell level in patients with inflammatory arthritides: enhanced activity in synovial fluid compared to blood. Br. J. Rheumatol.37, 7–14 (1998). ArticleCASPubMed Google Scholar
Chabaud, M. et al. Human interleukin-17: a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum.42, 963–970 (1999). This paper reports the first description of IL-17 in the rheumatoid arthritis synovium. ArticleCASPubMed Google Scholar
Goldberg, R., Wildbaum, G., Zohar, Y., Maor, G. & Karin, N. Suppression of ongoing adjuvant-induced arthritis by neutralizing the function of the p28 subunit of IL-27. J. Immunol.173, 1171–1178 (2004). ArticleCASPubMed Google Scholar
Batten, M. et al. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nature Immunol.7, 929–936 (2006). ArticleCAS Google Scholar
Stumhofer, J. S. et al. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nature Immunol.7, 937–945 (2006). ArticleCAS Google Scholar
Weaver, C. T., Hatton, R. D., Mangan, P. R. & Harrington, L. E. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol.25, 821–852 (2007). ArticleCASPubMed Google Scholar
Raza, K. et al. Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthritis Res. Ther.7, R784–R795 (2005). This is an important paper defining the early cytokine expression profile in synovial fluid. ArticleCASPubMedPubMed Central Google Scholar
Skapenko, A., Leipe, J., Lipsky, P. E. & Schulze-Koops, H. The role of the T cell in autoimmune inflammation. Arthritis. Res. Ther.7 (Suppl. 2), 4–14 (2005). Article Google Scholar
Ehrenstein, M. R. et al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFα therapy. J. Exp. Med.200, 277–285 (2004). ArticleCASPubMedPubMed Central Google Scholar
Nadkarni, S., Mauri, C. & Ehrenstein, M. R. Anti-TNF-α therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-β. J. Exp. Med.204, 33–39 (2007). ArticleCASPubMedPubMed Central Google Scholar
Weyand, C. M. & Goronzy, J. J. T-cell-targeted therapies in rheumatoid arthritis. Nature Clin. Pract. Rheumatol.2, 201–210 (2006). ArticleCAS Google Scholar
Schroder, A. E., Greiner, A., Seyfert, C. & Berek, C. Differentiation of B cells in the nonlymphoid tissue of the synovial membrane of patients with rheumatoid arthritis. Proc. Natl. Acad. Sci. USA93, 221–225 (1996). ArticleCASPubMedPubMed Central Google Scholar
Isomaki, P. et al. Prolonged exposure of T cells to TNF down-regulates TCRζ and expression of the TCR/CD3 complex at the cell surface. J. Immunol.166, 5495–5507 (2001). ArticleCASPubMed Google Scholar
Veys, E. M., Menkes, C. J. & Emery, P. A randomized, double-blind study comparing twenty-four-week treatment with recombinant interferon-γ versus placebo in the treatment of rheumatoid arthritis. Arthritis Rheum.40, 62–68 (1997). ArticleCASPubMed Google Scholar
Miossec, P. Interleukin-17 in rheumatoid arthritis: if T cells were to contribute to inflammation and destruction through synergy. Arthritis Rheum.48, 594–601 (2003). ArticleCASPubMed Google Scholar
Steinman, L. A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell-mediated tissue damage. Nature Med.13, 139–145 (2007). ArticleCASPubMed Google Scholar
Zheng, Y. et al. Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature445, 648–651 (2007). ArticleCASPubMed Google Scholar
Ikeuchi, H. et al. Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine. Arthritis Rheum.52, 1037–1046 (2005). ArticleCASPubMed Google Scholar
Yumoto, K. et al. Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice. Proc. Natl. Acad. Sci. USA99, 4556–4561 (2002). ArticleCASPubMedPubMed Central Google Scholar
Brennan, F. M. et al. Evidence that rheumatoid arthritis synovial T cells are similar to cytokine-activated T cells: involvement of phosphatidylinositol 3-kinase and nuclear factor κB pathways in tumor necrosis factor α production in rheumatoid arthritis. Arthritis Rheum.46, 31–41 (2002). ArticleCASPubMed Google Scholar
Dayer, J. M. & Burger, D. Cell–cell interactions and tissue damage in rheumatoid arthritis. Autoimmun. Rev.3 (Suppl. 1), 14–16 (2004). Google Scholar
McInnes, I. B., Leung, B. P. & Liew, F. Y. Cell–cell interactions in synovitis. Interactions between T lymphocytes and synovial cells. Arthritis Res.2, 374–378 (2000). ArticleCASPubMedPubMed Central Google Scholar
Edwards, J. C. et al. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N. Engl. J. Med.350, 2572–2581 (2004). ArticleCASPubMed Google Scholar
Takemura, S., Klimiuk, P. A., Braun, A., Goronzy, J. J. & Weyand, C. M. T cell activation in rheumatoid synovium is B cell dependent. J. Immunol.167, 4710–4718 (2001). ArticleCASPubMed Google Scholar
Ohata, J. et al. Fibroblast-like synoviocytes of mesenchymal origin express functional B cell-activating factor of the TNF family in response to proinflammatory cytokines. J. Immunol.174, 864–870 (2005). ArticleCASPubMed Google Scholar
Dorner, T. & Lipsky, P. E. Signalling pathways in B cells: implications for autoimmunity. Curr. Top. Microbiol. Immunol.305, 213–240 (2006). CASPubMed Google Scholar
Takemura, S. et al. Lymphoid neogenesis in rheumatoid synovitis. J. Immunol.167, 1072–1080 (2001). ArticleCASPubMed Google Scholar
Manzo, A. et al. Systematic microanatomical analysis of CXCL13 and CCL21 in situ production and progressive lymphoid organization in rheumatoid synovitis. Eur. J. Immunol.35, 1347–1359 (2005). ArticleCASPubMed Google Scholar
Weyand, C. M. & Goronzy, J. J. Ectopic germinal center formation in rheumatoid synovitis. Ann. NY Acad. Sci.987, 140–149 (2003). ArticleCASPubMed Google Scholar
Braun, A., Takemura, S., Vallejo, A. N., Goronzy, J. J. & Weyand, C. M. Lymphotoxin b-mediated stimulation of synoviocytes in rheumatoid arthritis. Arthritis Rheum.50, 2140–2150 (2004). ArticleCASPubMed Google Scholar
Lindhout, E. et al. Fibroblast-like synoviocytes from rheumatoid arthritis patients have intrinsic properties of follicular dendritic cells. J. Immunol.162, 5949–5956 (1999). CASPubMed Google Scholar
Kang, Y. M. et al. CD8 T cells are required for the formation of ectopic germinal centers in rheumatoid synovitis. J. Exp. Med.195, 1325–1336 (2002). ArticleCASPubMedPubMed Central Google Scholar
Brentano, F., Kyburz, D., Schorr, O., Gay, R. & Gay, S. The role of Toll-like receptor signalling in the pathogenesis of arthritis. Cell Immunol.233, 90–96 (2005). ArticleCASPubMed Google Scholar
Seibl, R. et al. Expression and regulation of Toll-like receptor 2 in rheumatoid arthritis synovium. Am. J. Pathol.162, 1221–1227 (2003). ArticleCASPubMedPubMed Central Google Scholar
Joosten, L. A. et al. Toll-like receptor 2 pathway drives streptococcal cell wall-induced joint inflammation: critical role of myeloid differentiation factor 88. J. Immunol.171, 6145–6153 (2003). ArticleCASPubMed Google Scholar
Sacre, S. M. et al. The Toll-like receptor adaptor proteins MyD88 and Mal/TIRAP contribute to the inflammatory and destructive processes in a human model of rheumatoid arthritis. Am. J. Pathol.170, 518–525 (2007). ArticleCASPubMedPubMed Central Google Scholar
Kelso, E. B. et al. Therapeutic promise of proteinase-activated receptor-2 antagonism in joint inflammation. J. Pharmacol. Exp. Ther.316, 1017–1024 (2006). ArticleCASPubMed Google Scholar
Kelso, E. B. et al. Expression and proinflammatory role of proteinase-activated receptor 2 in rheumatoid synovium: ex vivo studies using a novel proteinase-activated receptor 2 antagonist. Arthritis Rheum.56, 765–771 (2007). ArticleCASPubMed Google Scholar
Feldmann, M., Brennan, F. M. & Maini, R. N. Rheumatoid arthritis. Cell85, 307–310 (1996). This is a seminal review of the balance of cytokine activities in rheumatoid arthritis. ArticleCASPubMed Google Scholar
Feldmann, M., Brennan, F. M. & Maini, R. N. Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol.14, 397–440 (1996). ArticleCASPubMed Google Scholar
Keffer, J. et al. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J.10, 4025–4031 (1991). ArticleCASPubMedPubMed Central Google Scholar
Quinn, M. A. et al. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial. Arthritis Rheum.52, 27–35 (2005). ArticleCASPubMed Google Scholar
Ferrari-Lacraz, S. et al. Targeting IL-15 receptor-bearing cells with an antagonist mutant IL-15/Fc protein prevents disease development and progression in murine collagen-induced arthritis. J. Immunol.173, 5818–5826 (2004). ArticleCASPubMed Google Scholar
Baslund, B. et al. Targeting interleukin-15 in patients with rheumatoid arthritis: a proof-of-concept study. Arthritis Rheum.52, 2686–2692 (2005). ArticleCASPubMed Google Scholar
Dayer, J. M. & Bresnihan, B. Targeting interleukin-1 in the treatment of rheumatoid arthritis. Arthritis Rheum.46, 574–578 (2002). ArticleCASPubMed Google Scholar
Horai, R. et al. Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice. J. Exp. Med.191, 313–320 (2000). ArticleCASPubMedPubMed Central Google Scholar
Hoffman, H. M. et al. Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist. Lancet364, 1779–1785 (2004). ArticleCASPubMedPubMed Central Google Scholar
Choe, J. Y., Crain, B., Wu, S. R. & Corr, M. Interleukin 1 receptor dependence of serum transferred arthritis can be circumvented by Toll-like receptor 4 signaling. J. Exp. Med.197, 537–542 (2003). ArticleCASPubMedPubMed Central Google Scholar
McInnes, I. B., Liew, F. Y. & Gracie, J. A. Interleukin-18: a therapeutic target in rheumatoid arthritis? Arthritis Res. Ther.7, 38–41 (2005). ArticleCASPubMed Google Scholar
Netea, M. G. et al. IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1β and IL-6 production through a caspase 1-dependent mechanism. Proc. Natl Acad. Sci. USA102, 16309–16314 (2005). ArticleCASPubMedPubMed Central Google Scholar
Kokkola, R. et al. High mobility group box chromosomal protein 1: a novel proinflammatory mediator in synovitis. Arthritis Rheum.46, 2598–2603 (2002). ArticleCASPubMed Google Scholar
Morand, E. F., Leech, M. & Bernhagen, J. MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis. Nature Rev. Drug Discov.5, 399–410 (2006). ArticleCAS Google Scholar
van der Pouw Kraan, T. C. et al. Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients. Ann. Rheum. Dis. 18 January 2007 (doi:10.1136/ard.2006.063412). ArticleCASPubMedPubMed Central Google Scholar
Edwards, S. W. & Hallett, M. B. Seeing the wood for the trees: the forgotten role of neutrophils in rheumatoid arthritis. Immunol. Today18, 320–324 (1997). ArticleCASPubMed Google Scholar
Woolley, D. E. The mast cell in inflammatory arthritis. N. Engl. J. Med348, 1709–1711 (2003). ArticleCASPubMed Google Scholar
Lee, D. M. et al. Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science297, 1689–1692 (2002). ArticleCASPubMed Google Scholar
Paniagua, R. T. et al. Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritis. J. Clin. Invest.116, 2633–2642 (2006). ArticleCASPubMedPubMed Central Google Scholar
Dalbeth, N. & Callan, M. F. A subset of natural killer cells is greatly expanded within inflamed joints. Arthritis Rheum.46, 1763–1772 (2002). ArticlePubMed Google Scholar
Bresnihan, B. The safety and efficacy of interleukin-1 receptor antagonist in the treatment of rheumatoid arthritis. Semin. Arthritis Rheum.30, 17–20 (2001). ArticleCASPubMed Google Scholar
Schett, G. et al. High-sensitivity C-reactive protein and risk of nontraumatic fractures in the Bruneck study. Arch. Intern. Med.166, 2495–2501 (2006). ArticleCASPubMed Google Scholar
Pasco, J. A. et al. High-sensitivity C-reactive protein and fracture risk in elderly women. JAMA296, 1353–1355 (2006). ArticleCASPubMed Google Scholar
Goldring, S. R. Inflammatory mediators as essential elements in bone remodeling. Calcif. Tissue Int.73, 97–100 (2003). ArticleCASPubMed Google Scholar
Gravallese, E. M. et al. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum.43, 250–258 (2000). This paper reports the important early description of the erosive potential in inflammatory synovitis. ArticleCASPubMed Google Scholar
Yoshida, H. et al. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature345, 442–444 (1990). ArticleCASPubMed Google Scholar
Seitz, M., Loetscher, P., Fey, M. F. & Tobler, A. Constitutive mRNA and protein production of macrophage colony-stimulating factor but not of other cytokines by synovial fibroblasts from rheumatoid arthritis and osteoarthritis patients. Br. J. Rheumatol.33, 613–619 (1994). ArticleCASPubMed Google Scholar
Lacey, D. L. et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell93, 165–176 (1998). ArticleCASPubMed Google Scholar
Kong, Y. Y. et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature402, 304–309 (1999). ArticleCASPubMed Google Scholar
Shigeyama, Y. et al. Expression of osteoclast differentiation factor in rheumatoid arthritis. Arthritis Rheum.43, 2523–2530 (2000). ArticleCASPubMed Google Scholar
Horwood, N. J., Elliott, J., Martin, T. J. & Gillespie, M. T. Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells. Endocrinology139, 4743–4746 (1998). ArticleCASPubMed Google Scholar
Kotake, S. et al. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J. Clin. Invest.103, 1345–1352 (1999). ArticleCASPubMedPubMed Central Google Scholar
Simonet, W. S. et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell89, 309–319 (1997). ArticleCASPubMed Google Scholar
Lam, J. et al. TNF-α induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J. Clin. Invest.106, 1481–1488 (2000). ArticleCASPubMedPubMed Central Google Scholar
Li, P. et al. RANK signaling is not required for TNFα-mediated increase in CD11hi osteoclast precursors but is essential for mature osteoclast formation in TNFα-mediated inflammatory arthritis. J. Bone. Miner. Res.19, 207–213 (2004). ArticleCASPubMed Google Scholar
Ritchlin, C. T., Haas-Smith, S. A., Li, P., Hicks, D. G. & Schwarz, E. M. Mechanisms of TNF-α- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J. Clin. Invest.111, 821–831 (2003). ArticleCASPubMedPubMed Central Google Scholar
Wei, S., Kitaura, H., Zhou, P., Ross, F. P. & Teitelbaum, S. L. IL-1 mediates TNF-induced osteoclastogenesis. J. Clin. Invest.115, 282–290 (2005). ArticleCASPubMedPubMed Central Google Scholar
Wong, P. K. et al. Interleukin-6 modulates production of T lymphocyte-derived cytokines in antigen-induced arthritis and drives inflammation-induced osteoclastogenesis. Arthritis Rheum.54, 158–168 (2006). ArticleCASPubMed Google Scholar
Sato, K. et al. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J. Exp. Med.203, 2673–2682 (2006). ArticleCASPubMedPubMed Central Google Scholar
Takayanagi, H. et al. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ. Nature408, 600–605 (2000). ArticleCASPubMed Google Scholar
Udagawa, N. et al. Interleukin-18 (interferon-γ-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-γ to inhibit osteoclast formation. J. Exp. Med.185, 1005–1012 (1997). ArticleCASPubMedPubMed Central Google Scholar
Bertolini, D. R., Nedwin, G. E., Bringman, T. S., Smith, D. D. & Mundy, G. R. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature319, 516–518 (1986). ArticleCASPubMed Google Scholar
Diarra, D. et al. Dickkopf-1 is a master regulator of joint remodeling. Nature Med.13, 156–163 (2007). ArticleCASPubMed Google Scholar
Meyer, L. H., Franssen, L. & Pap, T. The role of mesenchymal cells in the pathophysiology of inflammatory arthritis. Best Pract. Res. Clin. Rheumatol.20, 969–981 (2006). ArticleCASPubMed Google Scholar
Lee, D. M. et al. Cadherin-11 in synovial lining formation and pathology in arthritis. Science315, 1006–1010 (2007). ArticleCASPubMed Google Scholar
Pap, T., Muller-Ladner, U., Gay, R. E. & Gay, S. Fibroblast biology: role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis. Arthritis Res.2, 361–367 (2000). ArticleCASPubMedPubMed Central Google Scholar
Burger, J. A., Zvaifler, N. J., Tsukada, N., Firestein, G. S. & Kipps, T. J. Fibroblast-like synoviocytes support B-cell pseudoemperipolesis via a stromal cell-derived factor-1- and CD106 (VCAM-1)-dependent mechanism. J. Clin. Invest.107, 305–315 (2001). ArticleCASPubMedPubMed Central Google Scholar
Pap, T. Direct interaction of immunoglobulins with synovial fibroblasts: a missing link in the pathogenesis of rheumatoid arthritis? Arthritis Res. Ther.7, 44–46 (2005). ArticleCASPubMed Google Scholar
Eberhardt, W., Huwiler, A., Beck, K. F., Walpen, S. & Pfeilschifter, J. Amplification of IL-1β-induced matrix metalloproteinase-9 expression by superoxide in rat glomerular mesangial cells is mediated by increased activities of NF-κB and activating protein-1 and involves activation of the mitogen-activated protein kinase pathways. J. Immunol.165, 5788–5797 (2000). ArticleCASPubMed Google Scholar
Catterall, J. B. et al. Synergistic induction of matrix metalloproteinase 1 by interleukin-1α and oncostatin M in human chondrocytes involves signal transducer and activator of transcription and activator protein 1 transcription factors via a novel mechanism. Arthritis Rheum.44, 2296–2310 (2001). ArticleCASPubMed Google Scholar
Van den Berg, W. B. Lessons from animal models of arthritis. Curr. Rheumatol. Rep.4, 232–239 (2002). ArticlePubMed Google Scholar
Pettipher, E. R., Higgs, G. A. & Henderson, B. Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint. Proc. Natl Acad. Sci. USA83, 8749–8753 (1986). ArticleCASPubMedPubMed Central Google Scholar
Joosten, L. A. B. et al. Interleukin-18 Promotes joint inflammation and induces interleukin-1-driven cartilage destruction. Am. J. Pathol.165, 959–967 (2004). ArticleCASPubMedPubMed Central Google Scholar
Dudler, J., Renggli-Zulliger, N., Busso, N., Lotz, M. & So, A. Effect of interleukin 17 on proteoglycan degradation in murine knee joints. Ann. Rheum. Dis.59, 529–532 (2000). ArticleCASPubMedPubMed Central Google Scholar
Lubberts, E. et al. Overexpression of IL-17 in the knee joint of collagen type II immunized mice promotes collagen arthritis and aggravates joint destruction. Inflamm. Res.51, 102–104 (2002). ArticleCASPubMed Google Scholar
Cai, L. et al. Pathways by which interleukin 17 induces articular cartilage breakdown in vitro and in vivo. Cytokine16, 10–21 (2001). ArticleCASPubMed Google Scholar
Veale, D. J. & Fearon, U. Inhibition of angiogenic pathways in rheumatoid arthritis: potential for therapeutic targeting. Best Pract. Res. Clin. Rheumatol.20, 941–947 (2006). ArticleCASPubMed Google Scholar
Paleolog, E. M. Angiogenesis in rheumatoid arthritis. Arthritis Res.4 (Suppl. 3), 81–90 (2002). Article Google Scholar
Haringman, J. J. & Tak, P. P. Chemokine blockade: a new era in the treatment of rheumatoid arthritis? Arthritis Res. Ther.6, 93–97 (2004). ArticleCASPubMedPubMed Central Google Scholar
Koch, A. E. Chemokines and their receptors in rheumatoid arthritis: future targets? Arthritis Rheum.52, 710–721 (2005). ArticlePubMed Google Scholar
Goekoop-Ruiterman, Y. P. et al. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. Arthritis Rheum.52, 3381–3390 (2005). ArticleCASPubMed Google Scholar
McInnes, I. B. Cytokines. In Kelley's Textbook of Rheumatology. 7th edn. (eds Harris, E. D. Jr. et al.) Ch. 15 (Elsevier Saunders, Philadelphia (2005). Google Scholar